Overview of the latest treatments for castration-resistant prostate cancer

被引:0
|
作者
Mohamed Bishr
Fred Saad
机构
[1] Centre de Recherche,Urology Division
[2] Centre Hospitalier de l'Université de Montréal,undefined
[3] Centre Hospitalier de l'Université de Montréal,undefined
来源
Nature Reviews Urology | 2013年 / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
In this Review, Saad and Bishr present an overview of the different management approaches for patients with CRPC, paying particular attention to recently approved agents and therapies that have shown promising results in phase III trials.
引用
收藏
页码:522 / 528
页数:6
相关论文
共 50 条
  • [41] Cabazitaxel for castration-resistant prostate cancer Reply
    de Bono, Johann Sebastian
    Sartor, Oliver
    LANCET, 2011, 377 (9760): : 122 - 123
  • [42] Satraplatin for the therapy of castration-resistant prostate cancer
    Sonpavde, Guru
    Sternberg, Cora N.
    FUTURE ONCOLOGY, 2009, 5 (07) : 931 - 940
  • [43] Effect of dutasteride on castration-resistant prostate cancer
    Azuma, Takeshi
    Matayoshi, Yukihide
    Sato, Yujiro
    Nagase, Yasuhi
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (01) : 133 - 136
  • [44] Leading causes of castration-resistant prostate cancer
    Lu, Mingqian
    Lu, Hongda
    Kong, Qingzhi
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (04) : 425 - 432
  • [45] PARP inhibition in castration-resistant prostate cancer
    Nappi, Lucia
    Gleave, Martin E.
    FUTURE ONCOLOGY, 2016, 12 (05) : 577 - 580
  • [46] About sorafenib in castration-resistant prostate cancer
    Colloca, G.
    Checcaglini, F.
    Venturino, A.
    ANNALS OF ONCOLOGY, 2008, 19 (10)
  • [47] Darolutamide for treatment of castration-resistant prostate cancer
    Rhea, L. P.
    Mendez-Marti, S.
    Aragon-Ching, J. B.
    DRUGS OF TODAY, 2020, 56 (03) : 185 - 193
  • [48] Managing Nonmetastatic Castration-resistant Prostate Cancer
    Mateo, Joaquin
    Fizazi, Karim
    Gillessen, Silke
    Heidenreich, Axel
    Perez-Lopez, Raquel
    Oyen, Wim J. G.
    Shore, Neal
    Smith, Matthew
    Sweeney, Christopher
    Tombal, Bertrand
    Tomlins, Scott A.
    de Bono, Johann S.
    EUROPEAN UROLOGY, 2019, 75 (02) : 285 - 293
  • [49] Sequencing of agents in castration-resistant prostate cancer
    Lorente, David
    Mateo, Joaquin
    Perez-Lopez, Raquel
    de Bono, Johann S.
    Attard, Gerhardt
    LANCET ONCOLOGY, 2015, 16 (06): : E279 - E292
  • [50] BRCA mutation and castration-resistant prostate cancer
    Spirina, L. V.
    ANNALS OF ONCOLOGY, 2018, 29